Hepatic encephalopathy (HE) is a clinical syndrome which can observe because of acute and chronic liver disorders such as hepatitis, liver failure caused by alcohol or drugs, autoimmune diseases, metabolic diseases, cirrhosis, types of tumors and infections. We aimed to investigate the effects of different doses of β-myrcene on the improvement of hepatic encephalopathy caused by thioacetamide (TAC) in male rats. In order to induce liver failure and acute damage in the studied animals, thioacetamide was administered to rats with a dose 100 mg/kg of body weight as an intraperitoneal (IP) injection with 24 h intervals and for seven consecutive days. After oral treatment of rats with β-myrcene at doses of 10, 25, and 50 mg/kg/day for 7 days, the cerebral edema (brain water content, BWC), the serum level of aspartate aminotransferase (AST), alanine transferase (ALT) and alkaline transferase (ALP), total protein (TP), bilirubin (TB), and ammonia as well as the level oxidant-antioxidant factors of malondialdehyde (MDA), glutathione peroxidase (GPx), Catalase (CAT) and superoxide dismutase enzymes (SOD) were evaluated. β-myrcene dose dependently reduced the BWC in Thioacetamide-induced acute hepatic encephalopathy in rats. Treatment of the TAC rats with β-myrcene especially at doses of 25 and 50 mg/kg significantly (p<0.001) moderated the serum level of these liver enzymes and ammonia compared to the untreated TAC mice. The analysis of the obtained data revealed that the treatment of the TAC rats with β-myrcene especially at doses of 25 and 50 mg/kg markedly (p<0.001) reduced the oxidative stress of MDA, whereas significantly (p<0.001) increased antioxidant enzymes of SOD, CAT, and GPx. Therefore, we can conclude that the treatment of the TAC rats with β-myrcene especially at doses of 25 and 50 mg/kg markedly reduced the oxidative stress of MDA, whereas significantly increased antioxidant enzymes and subsequently improved the thioacetamide-induced acute hepatic encephalopathy in rats. |
- Ferenci P. Hepatic encephalopathy. Gastroenterology report. 2017;5(2):138-47.
- Khungar V, Poordad F. Hepatic encephalopathy. Clinics in Liver Disease. 2012;16(2):301-20.
- Weiss N, Jalan R, Thabut D. Understanding hepatic encephalopathy. Intensive Care Medicine. 2018;44:231-4.
- Conde de la Rosa L, Goicoechea L, Torres S, Garcia-Ruiz C, Fernandez-Checa JC. Role of oxidative stress in liver disorders. Livers. 2022;2(4):283-314.
- Padmanaban S, Pully D, Samrot AV, Gosu V, Sadasivam N, Park IK, Radhakrishnan K, Kim DK. Rising Influence of Nanotechnology in Addressing Oxidative Stress-Related Liver Disorders. Antioxidants. 2023;12(7):1405.
- Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene—what are the potential health benefits of this flavouring and aroma agent?. Frontiers in nutrition. 2021;8:699666.
- Mustafa HN, El Awdan SA, Hegazy GA. Protective role of antioxidants on thioacetamide-induced acute hepatic encephalopathy: biochemical and ultrastructural study. Tissue and Cell. 2013;45(5):350-62.
- Sepehrinezhad A, Shahbazi A, Negah SS, Joghataei MT, Larsen FS. Drug-induced-acute liver failure: A critical appraisal of the thioacetamide model for the study of hepatic encephalopathy. Toxicology Reports. 2021;8:962-70.
- Rao KV, Reddy PV, Tong X, Norenberg MD. Brain edema in acute liver failure: inhibition by L-histidine. The American journal of pathology. 2010;176(3):1400-8.
- Bosoi CR, Rose CF. Oxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy. Metabolic brain disease. 2013;28:175-8.
- Mousa N, Abdel-Razik A, Zaher A, Hamed M, Shiha G, Effat N, Elbaz S, Elhelaly R, Hafez M, El-Wakeel N, Eldars W. The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial. Therapeutic Advances in Gastroenterology. 2016;9(5):684-91.
- Cardia GF, de Souza Silva-Comar FM, Bonetti CI, da Rocha EM, Zagoto M, do Amaral V, Bracht L, Silva-Filho SE, Bersani-Amado CA, Cuman RK. Hepatoprotective effect of β-myrcene pretreatment against acetaminophen-induced liver injury. Avicenna Journal of Phytomedicine. 2022;12(4):388.
- Gonzalez-Burgos E, Gomez-Serranillos MP. Terpene compounds in nature: a review of their potential antioxidant activity. Current medicinal chemistry. 2012;19(31):5319-41.
- Graßmann J. Terpenoids as plant antioxidants. Vitamins & Hormones. 2005;72:505-35.
- Wojtunik KA, Ciesla LM, Waksmundzka-Hajnos M. Model studies on the antioxidant activity of common terpenoid constituents of essential oils by means of the 2,2-diphenyl-1-picrylhydrazyl method. J Agric Food Chem. 2014;62(37):9088–94.
- Ciftci O, Ozdemir I, Tanyildizi S, Yildiz S, Oguzturk H. Antioxidative effects of curcumin, β-myrcene and 1,8-cineole against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced oxidative stress in rats liver. Toxicol Ind Health. 2011;27(5):447–453.
- Ciftci O, Oztanir MN, Cetin A. Neuroprotective effects of β-myrcene following global cerebral ischemia/reperfusion-mediated oxidative and neuronal damage in a C57BL/J6 mouse. Neurochem Res. 2014;39(9):1717–23.
- Bonamin F, Moraes TM, Dos RC, Kushima H, Faria FM, Silva MA, et al. The effect of a minor constituent of essential oil from Citrus aurantium: the role of β-myrcene in preventing peptic ulcer disease. Chem Biol Interact. 2014;212:11–19.
|